Another study showed that autotaxin, an LPA-producing enzyme, is highly secreted from ovarian cancer stem cells, and pharmacological inhibition of autotaxin decreases LPA-driven pro-tumorigenic potential of cancer stem cells and drug resistance [75]. This evidence concerns the gene ENPP2 and cancer.